Showing results (111-120 of 696) with videos related to
Sort By:
Pageof 70
Diabetes Research and Clinical Practice|May 22, 2018
Stratification of type 2 diabetes based on routine clinical markersNarges Safai, Ashfaq Ali, Peter Rossing, et al.Journal of Diabetes and Its Complications|August 30, 2025
Burden and progression of arterial calcification in type 1 diabetes predicts future cardiovascular diseaseHenrik Ø Hjortkjær, Peter Rossing, Klaus F KofoedJournal of Clinical Medicine|June 5, 2019
Effects of Dapagliflozin on Volume Status When Added to Renin-Angiotensin System InhibitorsMie K Eickhoff, Claire C J Dekkers, Bart J Kramers, et al.Journal of Diabetes and Its Complications|October 29, 2024
Effects of probiotics and fibers on markers of nephropathy, inflammation, intestinal barrier dysfunction and endothelial dysfunction in individuals with type 1 diabetes and albuminuria. The ProFOS StudyElisabeth B Stougaard, Ninna Hahn Tougaard, Suvanjaa Sivalingam, et al.Journal of Diabetes and Its Complications|March 15, 2018
Serum uric acid and progression of diabetic nephropathy in type 1 diabetesS Pilemann-Lyberg, M Lindhardt, Frederik Persson, et al.Diabetes, Obesity & Metabolism|July 7, 2023
Overall and inter-individual effect of four different drug classes on soluble urokinase plasminogen activator receptor in type 1 and type 2 diabetesViktor Rotbain Curovic, Morten B Houlind, Marjolein Y A M Kroonen, et al.Nature Reviews. Nephrology|April 3, 2024
Combination therapy for kidney disease in people with diabetes mellitusDaniël H van Raalte, Petter Bjornstad, David Z I Cherney, et al.Diabetes Care|January 20, 2023
Efficacy of Dapagliflozin by Baseline Diabetes Medications: A Prespecified Analysis From the DAPA-CKD StudyJelle M Beernink, Frederik Persson, Niels Jongs, et al.Diabetes Care|March 1, 2003
Smoking and progression of diabetic nephropathy in type 1 diabetesPeter Hovind, Peter Rossing, Lise Tarnow, et al.Acta Diabetologica|October 3, 2014
Pulse wave reflection is associated with diabetes duration, albuminuria and cardiovascular disease in type 1 diabetesSimone Theilade, Maria Lajer, Tine Willum Hansen, et al.Pageof 70